Vivani Medical
Uždarymo kaina
1.24
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
1.23
Max
1.26
Pajamos | 410K -6.4M |
|---|---|
Darbuotojai | 42 |
Kitas uždarbis | 2026-11-12 |
|---|
Rinkos kapitalizacija | 8.1M 110M |
|---|---|
Ankstesnė atidarymo kaina | 1.24 |
Ankstesnė uždarymo kaina | 1.24 |
Vivani Medical Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Susijusios naujienos
Akcijų palyginimas
Kainos pokytis
Vivani Medical Prognozė
Finansinės naujienos
Pardavimo ir administravimo išlaidos
Ikimokestinis pelnas
Pardavimai
Veiklos pelnas
$
Apie bendrovę Vivani Medical
Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.